<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology - Health AI Hub</title>
    <meta name="description" content="OnSight Pathology is a novel, platform-agnostic computer vision software designed to integrate real-time AI inferences into existing histopathology workflows. B">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04187v1" target="_blank">2512.04187v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jinzhen Hu, Kevin Faust, Parsa Babaei Zadeh, Adrienn Bourkas, Shane Eaton, Andrew Young, Anzar Alvi, Dimitrios George Oreopoulos, Ameesha Paliwal, Assem Saleh Alrumeh, Evelyn Rose Kamski-Hennekam, Phedias Diamandis
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04187v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04187v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">OnSight Pathology is a novel, platform-agnostic computer vision software designed to integrate real-time AI inferences into existing histopathology workflows. By utilizing continuous screen captures, it provides automated analysis directly from any digital slide viewer or live microscope feed, overcoming barriers associated with proprietary digital pathology solutions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This platform significantly impacts medical diagnosis by democratizing access to advanced AI tools in pathology, potentially reducing diagnostic subjectivity, improving accuracy, and extending expert-level analytical capabilities to resource-limited environments and diverse clinical scenarios.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application, OnSight Pathology, provides real-time, platform-agnostic computer vision inferences for medical image analysis in histopathology. It assists pathologists in disease classification (e.g., brain tumors), tumor grading (mitosis detection), and quantification of specific biomarkers (immunohistochemical stains), aiming to improve accuracy, reduce subjectivity, and expand access to specialized diagnostic expertise in both clinical and telepathology settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses critical challenges in histopathology: subjective interpretations, limited expert access, and deployment hurdles created by proprietary digital pathology AI platforms.</li>
                    
                    <li>Functions as a platform-agnostic computer vision tool, extracting real-time AI inferences from continuous screen captures of digital slide images or live microscope feeds.</li>
                    
                    <li>Operates locally on consumer-grade personal computers as a self-contained executable, ensuring cost-effectiveness, security, and minimal integration complexity for deployment.</li>
                    
                    <li>Demonstrated robustness across diverse routine histopathological tasks, including the classification of common brain tumor types, mitosis detection, and quantification of immunohistochemical stains.</li>
                    
                    <li>Validated using over 2,500 publicly available whole slide images across different slide viewers, alongside cases from a clinical digital pathology setup.</li>
                    
                    <li>Features a built-in multi-modal chat assistant providing verifiable image descriptions for enhanced quality control, moving beyond rigid class labels.</li>
                    
                    <li>Shows compatibility with live microscope camera feeds, including those from smartphones, highlighting its potential for deployment in analog, intra-operative, and telepathology settings.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>OnSight Pathology employs a computer vision approach that continuously captures screen content from any digital slide viewer or live microscope camera feed. These screen captures are processed locally on consumer-grade personal computers to generate real-time AI inferences. The software's utility and robustness were demonstrated through its application to over 2,500 publicly available whole slide images (WSIs) across various slide viewers, as well as on clinical digital pathology cases. Performance was assessed on key histopathological tasks such as brain tumor classification, mitosis detection, and quantification of immunohistochemical stains.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study found that OnSight Pathology effectively delivers real-time AI inferences for crucial histopathological tasks, including accurate classification of common brain tumor types, precise mitosis detection, and reliable quantification of immunohistochemical stains. It proved to be platform-agnostic, functioning seamlessly across different digital slide viewers, and exhibited compatibility with live microscope camera feeds, even from smartphones. The software's local operation and simple deployment enable secure and cost-effective integration, further enhanced by a multi-modal chat assistant for quality control.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>OnSight Pathology has the potential to profoundly impact clinical practice by providing an accessible, cost-effective, and secure means to integrate AI into existing pathology workflows without requiring specialized hardware or proprietary software. This can lead to improved diagnostic accuracy through objective, real-time analysis, faster turnaround times, and a significant reduction in inter-observer variability. Its compatibility with live feeds opens avenues for immediate AI assistance in intra-operative settings and facilitates advanced telepathology, expanding access to expert-level diagnostics globally.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the OnSight Pathology software itself. It primarily focuses on the demonstrated utility and broad applicability.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors suggest that compatibility with live microscope camera feeds, including smartphones, offers significant potential for future deployment in more analog, intra-operative, and telepathology settings. This implies future research and development focused on validating and optimizing the platform for these specific and diverse clinical environments.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Diagnostic medicine</span>
                    
                    <span class="tag">Telepathology</span>
                    
                    <span class="tag">Intraoperative consultation</span>
                    
                    <span class="tag">Neuropathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Computational pathology</span>
                    
                    <span class="tag tag-keyword">Artificial intelligence</span>
                    
                    <span class="tag tag-keyword">Histopathology</span>
                    
                    <span class="tag tag-keyword">Real-time inference</span>
                    
                    <span class="tag tag-keyword">Platform-agnostic</span>
                    
                    <span class="tag tag-keyword">Digital pathology</span>
                    
                    <span class="tag tag-keyword">Computer vision</span>
                    
                    <span class="tag tag-keyword">Mitosis detection</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The microscopic examination of surgical tissue remains a cornerstone of disease classification but relies on subjective interpretations and access to highly specialized experts, which can compromise accuracy and clinical care. While emerging breakthroughs in artificial intelligence (AI) offer promise for automated histological analysis, the growing number of proprietary digital pathology solutions has created barriers to real-world deployment. To address these challenges, we introduce OnSight Pathology, a platform-agnostic computer vision software that uses continuous custom screen captures to provide real-time AI inferences to users as they review digital slide images. Accessible as a single, self-contained executable file (https://onsightpathology.github.io/ ), OnSight Pathology operates locally on consumer-grade personal computers without complex software integration, enabling cost-effective and secure deployment in research and clinical workflows. Here we demonstrate the utility of OnSight Pathology using over 2,500 publicly available whole slide images across different slide viewers, as well as cases from our clinical digital pathology setup. The software's robustness is highlighted across routine histopathological tasks, including the classification of common brain tumor types, mitosis detection, and the quantification of immunohistochemical stains. A built-in multi-modal chat assistant provides verifiable descriptions of images, free of rigid class labels, for added quality control. Lastly, we show compatibility with live microscope camera feeds, including from personal smartphones, offering potential for deployment in more analog, inter-operative, and telepathology settings. Together, we highlight how OnSight Pathology can deliver real-time AI inferences across a broad range of pathology pipelines, removing key barriers to the adoption of AI tools in histopathology.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>